Journal
CLINICAL INFECTIOUS DISEASES
Volume 61, Issue 4, Pages 601-606Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/civ353
Keywords
biofilms; bacterial vaginosis; recurrent vulvovaginal candidiasis; treatment failure
Categories
Funding
- National Institute of Allergy and Infectious Diseases [K23AI106957-01A1, 1U01AI108509-01A1]
Ask authors/readers for more resources
Biofilms are microbial communities of surface-attached cells embedded in a self-produced extracellular matrix. They are of major medical significance because they decrease susceptibility to antimicrobial agents and enhance the spread of antimicrobial resistance. Biofilm-associated bacterial and fungal microorganisms have increasingly been recognized to play a role in multiple infectious diseases, particularly in their persistence and recurrence. More recently, biofilms have also been implicated in vaginal infections, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), particularly in the setting of treatment failure and recurrence. The purpose of this review is to discuss the impact of biofilms on the management and treatment of BV and recurrent VVC and highlight the need for additional research and development of novel therapeutics targeting pathogenic vaginal biofilms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available